60 Degrees Pharmaceuticals Funds Babesia spp Testing in Chronic Fatigue Patient Samples in NC State College of Veterinary Medicine Study

May 20, 2024

https://www.globenewswire.com/news-release/2024/05/20/2884789/0/en/60-Degrees-Pharmaceuticals-Funds-Babesia-spp-Testing-in-Chronic-Fatigue-Patient-Samples-in-NC-State-College-of-Veterinary-Medicine-Study.html

WASHINGTON, May 20, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today it will fund Babesia spp testing in chronic fatigue patient samples in a study to be conducted by North Carolina State College of Veterinary Medicine. Using PCR testing, the study will assess whether Babesia spp parasites are present in samples from patients with chronic fatigue symptoms who present with neurologic conditions. The study commences this month and is expected to run for 12 months.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.